Medizin
Refine
Year of publication
- 2020 (130) (remove)
Document Type
- Article (130)
Language
- English (130)
Has Fulltext
- yes (130)
Is part of the Bibliography
- no (130)
Keywords
- inflammation (6)
- COVID-19 (4)
- cancer (4)
- macrophage (4)
- SARS-CoV-2 (3)
- bladder cancer (3)
- miRNA (3)
- obesity (3)
- prevalence (3)
- quality of life (3)
- stroke (3)
- sulforaphane (3)
- CD44 (2)
- MSD (2)
- Magnetic resonance imaging (2)
- apoptosis (2)
- biomarker (2)
- bipolar disorder (2)
- coagulopathy (2)
- curcumin (2)
- dental education (2)
- dental profession (2)
- drug resistance (2)
- environmental tobacco smoke (2)
- growth (2)
- immunity (2)
- integrins (2)
- iron (2)
- machine learning (2)
- macrophages (2)
- microRNA (2)
- multiple sclerosis (2)
- natural killer cells (2)
- neuroblastoma (2)
- neurodegeneration (2)
- pain (2)
- polytrauma (2)
- proliferation (2)
- prostate cancer (2)
- proteome (2)
- psoriasis (2)
- public health (2)
- renal cell carcinoma (2)
- sphingosine 1-phosphate receptor (2)
- survivin (2)
- thymus (2)
- toxicity (2)
- 16 segment AHA model (1)
- A-FFIP (1)
- ABCB1 (1)
- ABCC1 (1)
- ACLF (1)
- ADGRE1 (1)
- ADHD (1)
- ADHD differential diagnosis (1)
- AML – acute myeloid leukemia (1)
- ASD-specific (1)
- Adverse drug reaction (1)
- Amitriptyline (1)
- Anal cancer (1)
- Anterior cruciate ligament reconstruction (1)
- Anticholinergic (1)
- Ataxia telangiectasia (1)
- Atm (1)
- Autism spectrum disorder (1)
- B cells (1)
- BCL6 (1)
- BIRC5 (1)
- Bee venom allergy (1)
- Body limbs (1)
- Borrelia (1)
- CAD/CAM (1)
- CD19 (1)
- CD41 (1)
- CD62P (1)
- CLP (1)
- COMP (1)
- CPT1A (1)
- Cancer treatment (1)
- Cardiovascular magnetic resonance (1)
- Central nervous system (1)
- Cerebrospinal fluid (1)
- Chemoradiotherapy (1)
- Cognitive impairment (1)
- Cognitive neurology (1)
- Cohort studies (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Computed axial tomography (1)
- Computer hardware (1)
- Computer software (1)
- Computers (1)
- Conservative treatment (1)
- Crohn's disease (1)
- CspA (1)
- CspZ (1)
- Cyp46a1 (1)
- DBS (1)
- DST (1)
- Data processing (1)
- Dental practice (1)
- Diagnostic error (1)
- Disabilities (1)
- Distribution limits (1)
- Double-blind placebo-controlled trial (1)
- Drug susceptibility testing (1)
- EGFR (1)
- EGFRvIII mutation (1)
- EMR1 (1)
- Early intervention (1)
- Elderly (1)
- Emotions (1)
- Epidural abscess (1)
- Evaluation (1)
- Evidence-based dentistry (1)
- Evidence-based medicine (1)
- Exercise challenge (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- F4/80 (1)
- Factor H (1)
- Finevo (1)
- Five-Konzept (1)
- Forced expiratory volume in 1 s (1)
- Functional clustering (1)
- Functional mitral regurgitation (1)
- GABA (1)
- Gait analysis (1)
- Gene expression (1)
- General practice (1)
- Genetics (1)
- HDAC (1)
- HIFT (1)
- HIV (1)
- HbA1c (1)
- Hepatocellular carcinoma (1)
- Hmox1 (1)
- Hymenoptera venom immunotherapy (1)
- IKKε (1)
- IL-1β (1)
- Immune suppression (1)
- Immunology (1)
- Imrt (1)
- Inflammatory bowel disease (1)
- Injury Severity Score (ISS) (1)
- Internet (1)
- Intravenous injections (1)
- Ireb2 (1)
- Joint loading (1)
- K-homology RNA-binding domain (1)
- Knees (1)
- LIR interaction, (1)
- Liver diseases (1)
- Liver transplantation (1)
- Longchain polyunsaturated fatty acids (1)
- Lymphoma (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MAGGIC score (1)
- MCAO (1)
- MICA (1)
- MMP14 (1)
- Machine learning algorithms (1)
- Malaria (1)
- Marker genes (1)
- Medical risk factors (1)
- Meta-analysis (1)
- Michael acceptor (1)
- Microglial cells (1)
- MitraClip (1)
- Mouse models (1)
- Mucomaix® matrix (1)
- Multimedication (1)
- Multimorbidity (1)
- Multiplate (1)
- Multiple-indication review (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- N2 (1)
- NADPH oxidase (1)
- NAFLD (1)
- NASH (1)
- NDBI (1)
- NF-κB pathway (1)
- NF-кB (1)
- NKG2D (1)
- NLRP3 inflammasomes (1)
- NTM (1)
- Nek1 (1)
- Neurons (1)
- Neuropathic pain (1)
- Neuropsychological testing (1)
- Neuropsychology (1)
- Non-tuberculous mycobacteria (1)
- Nordic questionnaire (1)
- Normal distribution (1)
- NoxO1 (1)
- OGTT (1)
- OSA (1)
- Optogenetics (1)
- OspE (1)
- Osteoarthritis (1)
- Overwintering (1)
- PYGL (1)
- Patient safety (1)
- Patterns of care (1)
- Pgrmc1 (1)
- Phenotypic plasticity (1)
- Physicians (1)
- PolySUMOylation (1)
- Polypharmacy (1)
- Primary health care (1)
- Probability density (1)
- Probability distribution (1)
- Prototypes (1)
- Psychological stress (1)
- Psychology (1)
- QbTest® (1)
- Quality of life (1)
- Quantra (1)
- Questionnaire (1)
- RNA chaperone (1)
- RNA therapeutics (1)
- RNF4 (1)
- Radiation exposure (1)
- Randomised trial (1)
- Regret (1)
- Reliability (1)
- Rush protocol (1)
- S1P1–5 (1)
- SCA2 (1)
- SENP6 (1)
- SF-36 (1)
- SNORD95 (1)
- SUMO chains (1)
- Seattle heart failure model (1)
- Serum biomarker (1)
- Side effects (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Software tools (1)
- Spinocerebellar ataxia type 2 (1)
- Sports and exercise medicine (1)
- StUbL (1)
- Statistical data (1)
- Strength training (1)
- Sub-segmentation (1)
- Sub-zero exposure (1)
- Surgery (1)
- Survey (1)
- Surveys (1)
- T cell receptor (1)
- T-cell receptor (1)
- TAPSE (1)
- TBK1 (1)
- TGR(mREN2)27 (1)
- TRIMs (1)
- Tfrc (1)
- Torque (1)
- Total hip arthroplasty (1)
- Transportation (1)
- Treg cell (1)
- Ulcerative colitis (1)
- Ultra-rush protocol (1)
- Uncertainty (1)
- VIM (1)
- Validation (1)
- Vespid venom allergy (1)
- Vmem (1)
- Western diet (1)
- Winter survival (1)
- YM155 (1)
- Yellow fluorescent protein (1)
- acetylation (1)
- acetylcholinesterase (1)
- acquired drug resistance (1)
- actin dynamics (1)
- activities of daily life (1)
- acute lymphoblastic leukemia (1)
- acute respiratory distress syndrome (1)
- acute-on-chronic liver failure (ACLF) (1)
- adhesion (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adoptive cancer immunotherapy (1)
- affective disorder (1)
- affective disorders (1)
- air flow (1)
- alcoholic hepatitis (1)
- algorithm (1)
- allergy (1)
- alpharetroviral vector (1)
- amlexanox (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anal cancer (1)
- anti-tumor activity (1)
- antireflux surgery (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- aspiration (1)
- aspirin (1)
- asthma (1)
- ataxia telangiectasia (1)
- atopy (1)
- augmentation (1)
- autophagy (1)
- bacterial translocation (1)
- bibliometrics (1)
- bio imaging (1)
- bioactive lipids (1)
- bioavailability (1)
- bioluminescence (1)
- biomarkers (1)
- biopsy naïve (1)
- blood (1)
- blood pressure (1)
- blood-brain barrier (1)
- body mass index (1)
- bone healing (1)
- bone marrow mononuclear cells (1)
- brain shift (1)
- brain tumor (1)
- breast cancer (1)
- butyrylcholinesterase (1)
- bypass (1)
- cancer immunobiology (1)
- carcinoma (1)
- cardiac surgery (1)
- cardiothoracic surgery (1)
- cell and focal adhesion (1)
- cell proliferation (1)
- cell survival (1)
- cellular reaction (1)
- ceramides (1)
- cervical cancer (1)
- chaperones (1)
- chelation therapy (1)
- chemoprotection (1)
- chemoresistance (1)
- chemotaxis (1)
- chemotherapy (1)
- chimeric antigen receptor (1)
- chloroplasts (1)
- cholinesterase (1)
- chronic inflammation (1)
- clopidogrel (1)
- coagulation (1)
- cognition (1)
- collagen-based matrix (1)
- colorectal cancer (1)
- colorectal cancer (CRC) (1)
- complement (1)
- complications (1)
- contamination (1)
- continuous performance test (1)
- contralateral delay activity (1)
- coronavirus (1)
- coronavirus disease 2019 (1)
- cortex, gray matter (1)
- covalent drugs (1)
- critical care (1)
- cyclin Y (1)
- cyclophosphamide (1)
- cystic fibrosis (1)
- cytarabin (1)
- cytokine storm (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- data science (1)
- debris (1)
- declaration of tobacco ingredients (1)
- decompensated liver cirrhosis (1)
- deep sedation (1)
- deferred treatment (1)
- delayed treatment (1)
- demineralized bone matrix (1)
- dendritic cells (1)
- dental assistants (1)
- dentist (1)
- dentists (1)
- diabetes (1)
- diabetes mellitus (1)
- diabetes therapy (1)
- diffusion tensor imaging (1)
- diuretics (1)
- dog study (1)
- dual antiplatelet therapy (1)
- dysphagia (1)
- early detection (1)
- effort (1)
- electrolytic cleaning (1)
- electrophilic fatty acids (1)
- encoding (1)
- epidemics (1)
- epidemiology (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- essential tremor (1)
- everolimus (1)
- ex-Gaussian analysis (1)
- exercise (1)
- exertion (1)
- experimental pain models (1)
- feeder cells (1)
- fibroblasts (1)
- fibrosis (1)
- fingolimod (1)
- flow cytometry (1)
- fractional anisotropy (1)
- fractionation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- fundoplication (1)
- gastroesophageal reflux (1)
- gene regulation (1)
- gene therapy (1)
- genetic predisposition (1)
- geriatric patients (1)
- glioblastoma (1)
- glucose metabolism (1)
- healthcare workers (1)
- heat stress (1)
- hematopoietic stem and progenitor cells (1)
- hemorrhagic transformation (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- high-throughput nucleotide sequencing (1)
- histological outcomes (1)
- histology (1)
- histomorphometry (1)
- host-pathogen interaction (1)
- human decellularized dermis (1)
- human genomics (1)
- hybrid abutment (1)
- hypoxia (1)
- imaging (1)
- immune checkpoint (1)
- immune defense (1)
- immune response (1)
- immunotherapy (1)
- in vitro models (1)
- indoor air pollution (1)
- induced membrane (1)
- infection (1)
- inflammatory bowel disease (1)
- inhibitors (1)
- inositol signaling (1)
- integrin (1)
- interferon type III (1)
- intrinsic drug resistance (1)
- inflammation (1)
- iron overload versus deprivation (1)
- joint contact forces (1)
- knee adduction moment (1)
- lentiviral vector (1)
- leukopenia (1)
- lichen extracts (1)
- lipocalin-2 (1)
- lipoxin A4 (1)
- liquid PRF (1)
- liver fibrosis (1)
- long-term potentiation (1)
- longevity (1)
- mTOR (1)
- maintenance (1)
- major depression (MD) (1)
- major depressive disorder (MDD) (1)
- maternal tobacco smoke (1)
- matrix metalloproteinases (1)
- mean diffusivity (1)
- mechanism of action (1)
- melanoma (1)
- membrane potential (1)
- mesenchymal stem cell (1)
- mesenchymal stromal cells (1)
- mesenchymal stromal/stem cells (1)
- metabolic syndrome (1)
- miR-142-3p (1)
- miR-181 (1)
- mice (1)
- microlesions (1)
- migration (1)
- migration and invasion (1)
- monocyte chemotactic protein 1 (MCP-1) (1)
- monotype abutment (1)
- monsoon (1)
- mortality analysis (1)
- mouse model (1)
- musculoskeletal (1)
- musculoskeletal disorders (1)
- musculoskeletal inflammation (1)
- musculoskeletal modeling (1)
- musculoskeletal pain (1)
- natural cytotoxicity (1)
- naturalistic sample (1)
- neurexin (1)
- neurocognition (1)
- neurogenesis (1)
- neuronal maturation (1)
- next-generation sequencing (1)
- nitroalkylation (1)
- non-malignant hematological diseases (1)
- nucleotide metabolism (1)
- nutrient endocytosis (1)
- occupational health (1)
- oncogenic signaling (1)
- orientation (1)
- osteoarthritis (1)
- osteogenic sarcoma cells (1)
- ouabain (1)
- outcome (1)
- outside-in signaling (1)
- passive smoke (1)
- patient’s decree (1)
- pediatric (1)
- pediatric epilepsy (1)
- periimplantitis (1)
- perineurium (1)
- phage display (1)
- placenta (1)
- planimetric measurement (1)
- plasma (1)
- point of care (1)
- poly(A)-tail (1)
- portal hypertension (1)
- post-exercise hypotension (1)
- post-translational modifications (1)
- posterior fossa tumor (1)
- postmonsoon (1)
- postoperative delirium (1)
- ppi1 (1)
- prediabetes (1)
- prevention (1)
- prognosis (1)
- prognostic marker (1)
- psoriatic arthritis (1)
- qRT-PCR (1)
- qRT-PCR detection (1)
- quantitative proteomics (1)
- questionnaire (1)
- radical prostatectomy (1)
- radiosensitization (1)
- rat femur critical size defect (1)
- re-osseointegration (1)
- regulatory T cell (1)
- regulatory T helper cells (1)
- renal cell cancer (1)
- renal tubular epithelial cells (1)
- repeat biopsy (1)
- reperfusion injury (1)
- resolution of inflammation (1)
- risk factor (1)
- rotational thromboelastometry (1)
- sarcopenia (1)
- sciatic nerve (1)
- screening (1)
- second-hand smoke (1)
- selection (1)
- selective autophagy receptor (1)
- serum (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- severe congenital neutropenia (1)
- severely injured (1)
- short linear motifs (SLiMs) (1)
- sickle cell anemia (1)
- signaling (1)
- smoking in pregnancy (1)
- soluble MICA (1)
- spatial learning (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- sphingosine 1-phoshate (1)
- sphingosine 1-phosphate (1)
- sphingosine 1-phosphate antagonistst/inhibitors (1)
- sphingosine 1-phosphate metabolism (1)
- sphingosine 1-phosphate signaling (1)
- sphingosine kinase (1)
- sphingosine-1-phosphate (1)
- spreading (1)
- starvation (1)
- steatosis (1)
- stretching (1)
- swallowing (1)
- synaptic plasticity (1)
- synuclein (1)
- systematic biopsy (1)
- targeted biopsy (1)
- tauopathies (1)
- tauopathy (1)
- test protocol (1)
- thalassemia (1)
- therapy monitoring (1)
- therapy resistance (1)
- thiazolidine and perhydrothiazine derivatives of aldophosphamide and I-aldophosphamide (1)
- thrombopenia (1)
- thrombosis (1)
- tick (1)
- tobacco control (1)
- tobacco products (1)
- toc64 (1)
- total hip replacement (1)
- tracking (1)
- transferrin (1)
- transjugular intrahepatic portosystemic shunt (TIPS) (1)
- translational medical research (1)
- translocon (1)
- transrectal prostate biopsy (1)
- transverse axis (1)
- trauma registry (1)
- traumaticbraininjury(TBI) (1)
- trophoblast (1)
- tumor adhesion (1)
- tumor growth (1)
- tumor migration (1)
- tumor pain (1)
- tumor progression (1)
- tyrosine kinase receptor signaling (1)
- ultrasonic cleaning (1)
- unconventional T cell (1)
- ventralis intermedius nucleus (1)
- vertical transmission (1)
- vitamin D (1)
- vitamin D deficiency (1)
- vitamin D metabolites (1)
- volatile sedation (1)
- waiting time (1)
- walking (1)
- wheezing (1)
- working memory (1)
- workplace health promotion (1)
- xenograft (1)
- fibrogenesis (1)
- fingolimod (1)
Institute
Study design: Systematic review. Background and objectives: Preoperative neuromuscular function is predictive for knee function and return to sports (RTS) after reconstruction of the anterior cruciate ligament (ACL). The aim of this review was to examine the potential benefits of prehabilitation on pre-/postoperative objective, self-reported and RTS-specific outcomes. Methods: A systematic search was conducted within three databases. From the 1.071 studies screened, two randomized control trials (RCTs), two control trials (CTs) and two cohort studies (CS) met the inclusion criteria. Methodological quality rating adopted the PEDro- (RCT, CT) or Newcastle-Ottawa-Scale (CS). Results and conclusions: Methodological quality of the included studies was moderate (PEDro score: 6.5 ± 1.7; range 4 to 9). Two studies reported higher increases of the maximal quadriceps torque from baseline to pre-reconstruction: one study in the limb symmetry index (LSI), and one in both legs of the prehabilitation group compared to the controls. At 12-weeks post-reconstruction, one study (from two) indicated that the prehabilitation group had a lesser post-operative decline in the single-leg-hop for distance LSI (clinically meaningful). Similar findings were found in terms of quadriceps strength LSI (one study). At both pre-reconstruction (three studies) and two-year post-surgery (two studies), the prehabilitation groups reached significantly higher self-reported knee function (clinically meaningful) than the controls. RTS tended to be faster (one study). At two years post-surgery, RTS rates (one study) were higher in the prehabilitation groups. The results provide evidence for the relevance of prehabilitation prior to ACL-reconstruction to improve neuromuscular and self-reported knee function as well as RTS. More high quality confirmatory RCTs are warranted.
Class I and II histone deacetylases (HDAC) are considered important regulators of immunity and inflammation. Modulation of HDAC expression and activity is associated with altered inflammatory responses but reports are controversial and the specific impact of single HDACs is not clear. We examined class I and II HDACs in TLR-4 signaling pathways in murine macrophages with a focus on IκB kinase epsilon (IKKε) which has not been investigated in this context before. Therefore, we applied the pan-HDAC inhibitors (HDACi) trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA) as well as HDAC-specific siRNA. Administration of HDACi reduced HDAC activity and decreased expression of IKKε although its acetylation was increased. Other pro-inflammatory genes (IL-1β, iNOS, TNFα) also decreased while COX-2 expression increased. HDAC 2, 3 and 4, respectively, might be involved in IKKε and iNOS downregulation with potential participation of NF-κB transcription factor inhibition. Suppression of HDAC 1–3, activation of NF-κB and RNA stabilization mechanisms might contribute to increased COX-2 expression. In conclusion, our results indicate that TSA and SAHA exert a number of histone- and HDAC-independent functions. Furthermore, the data show that different HDAC enzymes fulfill different functions in macrophages and might lead to both pro- and anti-inflammatory effects which have to be considered in therapeutic approaches.
Objectives: The ongoing coronavirus pandemic is challenging, especially in severely affected patients who require intubation and sedation. Although the potential benefits of sedation with volatile anesthetics in coronavirus disease 2019 patients are currently being discussed, the use of isoflurane in patients with coronavirus disease 2019–induced acute respiratory distress syndrome has not yet been reported. Design: We performed a retrospective analysis of critically ill patients with hypoxemic respiratory failure requiring mechanical ventilation. Setting: The study was conducted with patients admitted between April 4 and May 15, 2020 to our ICU. Patients: We included five patients who were previously diagnosed with severe acute respiratory syndrome coronavirus 2 infection. Intervention: Even with high doses of several IV sedatives, the targeted level of sedation could not be achieved. Therefore, the sedation regimen was switched to inhalational isoflurane. Clinical data were recorded using a patient data management system. We recorded demographical data, laboratory results, ventilation variables, sedative dosages, sedation level, prone positioning, duration of volatile sedation and outcomes. Measurements & Main Results: Mean age (four men, one women) was 53.0 (± 12.7) years. The mean duration of isoflurane sedation was 103.2 (± 66.2) hours. Our data demonstrate a substantial improvement in the oxygenation ratio when using isoflurane sedation. Deep sedation as assessed by the Richmond Agitation and Sedation Scale was rapidly and closely controlled in all patients, and the subsequent discontinuation of IV sedation was possible within the first 30 minutes. No adverse events were detected. Conclusions: Our findings demonstrate the feasibility of isoflurane sedation in five patients suffering from severe coronavirus disease 2019 infection. Volatile isoflurane was able to achieve the required deep sedation and reduced the need for IV sedation.
Introduction: Gastroesophageal reflux disease (GERD) is associated with accelerated decline in lung health in children with cystic fibrosis (CF). Thus, antireflux surgery (ARS) is offered to a selected CF cohort with refractory GERD, but outcomes remain poorly investigated. This study aimed to determine the incidence of GERD in children with CF and to evaluate complications and outcomes of ARS. Materials and Methods: A systematic literature-based search was conducted using various online databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The number of GERD cases in pediatric CF cohorts who underwent diagnostic investigation(s) was recorded. Data on postoperative complications and outcomes (including symptoms, lung function, and nutritional status) following ARS were analyzed. Results: Ten articles (n = 289 patients) met the defined inclusion criteria (51% male; age range, 0.5 month–36 years). The overall incidence of GERD was 46% (range, 19–81%), derived from seven studies (n = 212 patients). Four publications (n = 82 patients) reported on ARS due to uncontrolled GERD. All ARSs were Nissen fundoplication (majority with gastrostomy placement). Major postoperative complications occurred in 15 (18%) patients, two required redo-ARS. Median follow-up time was 2 years (range, 3 months–6 years); 59% showed symptom improvement, and pulmonary exacerbations and decline in lung function were reduced. Nutritional status mainly improved in milder CF cases. There were no deaths related to ARS. Conclusion: Approximately half of pediatric CF patients have GERD. Published data for children with CF are limited and heterogeneous in terms of GERD diagnosis and outcomes following ARS. However, ARS has shown to slow the deterioration of lung function in CF.
Diabetes is associated with platelet hyper-reactivity and enhanced risk of thrombosis development. Here we compared protein expression in platelets from healthy donors and diabetic patients to identify differentially expressed proteins and their possible function in platelet activation. Mass spectrometry analyses identified cyclin Y (CCNY) in platelets and its reduced expression in platelets from diabetic patients, a phenomenon that could be attributed to the increased activity of calpains. To determine the role of CCNY in platelets, mice globally lacking the protein were studied. CCNY-/- mice demonstrated lower numbers of circulating platelets but platelet responsiveness to thrombin and a thromboxane A2 analogue were comparable with that of wild-type mice, as was agonist-induced α and dense granule secretion. CCNY-deficient platelets demonstrated enhanced adhesion to fibronectin and collagen as well as an attenuated spreading and clot retraction, indicating an alteration in “outside in” integrin signalling. This phenotype was accompanied by a significant reduction in the agonist-induced tyrosine phosphorylation of β3 integrin. Taken together we have shown that CCNY is present in anucleated platelets where it is involved in the regulation of integrin-mediated outside in signalling associated with thrombin stimulation.
Background: Current literature is inconsistent regarding the risk of severe side effects using accelerated induction protocols in Hymenoptera venom immunotherapy (VIT). In addition, several data indicate the influence of purity grade of venom preparation on tolerability. We evaluated the safety and tolerability of ultra-rush and rush build-up protocols using purified and non-purified venom preparations. Methods: Retrospective single-center study of 581 VIT inductions (325 ultra-rush and 256 rush protocols) from 2005 to 2018 in 559 patients with bee and vespid venom allergy using aqueous purified (ALK SQ®) for ultra-rush protocol and aqueous non-purified (ALK Reless®) venom preparations for rush protocol. Results: Urticaria (8% vs. 3.1%, p = 0,013) and dose reductions (4.3% vs. 1.2%, p = 0,026) were significantly more frequent in the ultra-rush group. Overall rate of moderate-to-severe side effects (anaphylaxis ≥grade 2 according to Ring and Meβmer) was low and did not differ significantly between protocols (p = 0.105). Severe events (grade 4 anaphylaxis) were not reported. Discontinuation rate was very low in both cohorts (0.6% vs 1.2%). The higher purity grade of venom preparations in the ultra-rush cohort did not improve tolerability. The bee venom group showed a non-significant trend towards higher incidence of mild reactions (urticaria), resulting in more frequent dose reductions and antiallergic therapy. Conclusion: Rush and ultra-rush protocols show an excellent safety profile with only infrequent and mild anaphylactic reactions in bee and vespid venom allergy. Ultra-rush immunotherapy reduces the duration of the inpatient build-up phase setting and thus is viewed by the authors as preferred treatment in Hymenoptera venom allergic patients.
Background: Dental professionals are subjected to higher risks for musculoskeletal disorders (MSDs) than other professional groups, especially the hand region. This study aims to investigate the prevalence of hand complaints among dentists (Ds) and dental assistants (DAs) and examines applied therapies. Methods: For this purpose, an online questionnaire analysed 389 Ds (240female/149male) and 406 DAs (401female/5male) working in Germany. The self-reported data of the two occupational groups were compared with regard to the topics examined. The questionnaire was based on the Nordic Questionnaire (self-reported lifetime, 12-month and 7-day MSDs prevalence of the hand, the conducted therapy and its success), additional occupational and sociodemographic questions as well as questions about specific medical conditions. Results: 30.8% of Ds affirmed MSDs in the hand at any time in their lives, 20.3% in the last twelve months and 9.5% in the last seven days. Among DAs, 42.6% reported a prevalence of MSDs in the hand at any time in their lives, 31.8% in the last 12 months and 15.3% in the last seven days. 37.5% of the Ds and 28.3% of the DAs stated that they had certain treatments. For both, Ds and DAs, physiotherapy was the most frequently chosen form of therapy. 89.7% of Ds and 63.3% of DAs who received therapy reported an improvement of MSDs. Conclusion: Although the prevalence of MSDs on the hand is higher among DAs than among Ds, the use of therapeutic options and the success of therapy is lower for DAs compared to Ds.
This study deals with 3D laser investigation on the border between the human lymph node T-zone and germinal centre. Only a few T-cells specific for antigen selected B-cells are allowed to enter germinal centres. This selection process is guided by sinus structures, chemokine gradients and inherent motility of the lymphoid cells. We measured gaps and wall-like structures manually, using IMARIS, a 3D image software for analysis and interpretation of microscopy datasets. In this paper, we describe alpha-actin positive and semipermeable walls and wall-like structures that may hinder T-cells and other cell types from entering germinal centres. Some clearly defined holes or gaps probably regulate lymphoid traffic between T- and B-cell areas. In lymphadenitis, the morphology of this border structure is clearly defined. However, in case of malignant lymphoma, the wall-like structure is disrupted. This has been demonstrated exemplarily in case of angioimmunoblastic T-cell lymphoma. We revealed significant differences of lengths of the wall-like structures in angioimmunoblastic T-cell lymphoma in comparison with wall-like structures in reactive tissue slices. The alterations of morphological structures lead to abnormal and less controlled T- and B-cell distributions probably preventing the immune defence against tumour cells and infectious agents by dysregulating immune homeostasis.
Background: The intraoperative blood loss is estimated daily in the operating room and is mainly done by visual techniques. Due to local standards, the surgical sponge colours can vary (e.g. white in US, green in Germany). The influence of sponge colour on accuracy of estimation has not been in the focus of research yet. Material and methods: A blood loss simulation study containing four “bleeding” scenarios each per sponge colour were created by using expired whole blood donation samples. The blood donations were applied to white and green surgical sponges after dilution with full electrolyte solution. Study participants had to estimate the absorbed blood loss in sponges in all scenarios. The difference to the reference blood loss was analysed. Multivariate linear regression analysis was performed to investigate other influence factors such as staff experience and sponge colour. Results: A total of 53 anaesthesists participated in the study. Visual estimation correlated moderately with reference blood loss in white (Spearman's rho: 0.521; p = 3.748*10−16) and green sponges (Spearman's rho: 0.452; p = 4.683*10−12). The median visually estimated blood loss was higher in white sponges (250ml IRQ 150–412.5ml) than in green sponges (150ml IQR 100-300ml), compared to reference blood loss (103ml IQR 86–162.8). For both colour types of sponges, major under- and overestimation was observed. The multivariate statistics demonstrates that fabric colours have a significant influence on estimation (p = 3.04*10−10), as well as clinician’s qualification level (p = 2.20*10−10, p = 1.54*10−08) and amount of RBL to be estimated (p < 2*10−16). Conclusion: The deviation of correct blood loss estimation was smaller with white surgical sponges compared to green sponges. In general, deviations were so severe for both types of sponges, that it appears to be advisable to refrain from visually estimating blood loss whenever possible and instead to use other techniques such as e.g. colorimetric estimation.
Objectives: In this study, localization accuracy and sensitivity to acoustic interaural time differences (ITDs) in subjects using cochlear implants with combined electric-acoustic stimulation (EAS) were assessed and compared with the results of a normal hearing control group. Methods: Eight CI users with EAS (2 bilaterally implanted, 6 unilaterally implanted) and symmetric binaural acoustic hearing and 24 normal hearing subjects participated in the study. The first experiment determined mean localization error (MLE) for different angles of sound incidence between ± 60° (frontal and dorsal presentation). The stimuli were either low-pass, high-pass or broadband noise bursts. In a second experiment, just noticeable differences (JND) of ITDs were measured for pure tones of 125 Hz, 250 Hz and 500 Hz (headphone presentation). Results: Experiment 1: MLE of EAS subjects was 8.5°, 14.3° and 14.7°, (low-, high-pass and broadband stimuli respectively). In the control group, MLE was 1.8° (broadband stimuli). In the differentiation between sound incidence from front and back, EAS subjects performed on chance level. Experiment 2: The JND-ITDs were 88.7 μs for 125 Hz, 48.8 μs for 250 Hz and 52.9 μs for 500 Hz (EAS subjects). Compared to the control group, JND-ITD for 125 Hz was on the same level of performance. No statistically significant correlation was found between MLE and JND-ITD in the EAS cohort. Conclusions: Near to normal ITD sensitivity in the lower frequency acoustic hearing was demonstrated in a cohort of EAS users. However, in an acoustic localization task, the majority of the subjects did not reached the level of accuracy of normal hearing. Presumably, signal processing time delay differences between devices used on both sides are deteriorating the transfer of precise binaural timing cues.